FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Advanced Urologic Cancer Consensus Conference (AUC3) 2025 - ACS Journals
Gevorg Tamamyan: We Can Do More…
Richard R. Barakat: A Powerful Northwell Cancer Institute–START Collaboration Bringing Early-Phase Trials to Patients
Senator Ron Johnson Thanks Secretary Kennedy for Advocacy in Early Sscreening for Rare Diseases
Arnaud Lallouette: Energy, Ambition, and Teamwork Across the Servier Performance Summit 2025 Tour
Meet the 2025 BCRF-AACR Career Development Award Recipients - AACR
Clifford Hudis Encourages ASCO Members to Participate in the 2025 Survey as It Nears Close
